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Objective: Although stereotactic EEG (sEEG) has become a widely used intracranial EEG technique, the signifi
cance of subclinical seizures (SCS) recorded on sEEG is unclear and studies examining this finding on sEEG are
limited. We investigated (1) the prevalence of SCS in patients undergoing sEEG and clinical factors associated
with their presence, (2) how often the subclinical seizure onset zone (SOZ) colocalizes with clinical SOZ, (3) the
association of SCS and surgical outcomes, and (4) the influence of resection of the subclinical SOZ on surgical
outcome.
Methods: We reviewed all patients who underwent intracranial monitoring with sEEG at our institution from
2015 through 2020 (n=169). Patient and seizure characteristics were recorded, as was concordance of sub
clinical and clinical seizures and post-surgical outcomes.
Results: SCS were observed during sEEG monitoring in 84 of 169 patients (50%). There was no difference in the
prevalence of SCS based on imaging abnormalities, temporal vs extratemporal SOZ, number of electrodes, or
pathology. SCS were more common in females than males (62% vs 40%, p=0.0054). SCS had complete
concordance with clinical SOZ in 40% of patients, partial concordance in 29%, overlapping in 19%, and
discordant in 12%. Eighty-three patients had surgery, 44 of whom had SCS. There was no difference in excellent
outcome (ILAE 12 or 2) based on the presence of SCS or SCS concordance with clinical SOZ; however, there were
improved outcomes in patients with complete resection of the subclinical SOZ compared with patients with
incomplete resection (p =0.013).
Significance: These findings demonstrate that SCS are common during sEEG and colocalize with the clinical SOZ
in most patients. Discordance with clinical SOZ does not necessarily predict poor surgical outcome; rather,
complete surgical treatment of the subclinical SOZ correlates with excellent outcome. For unclear reasons,
subclinical seizures occurred more commonly in females than males.

1. Introduction
Drug-resistant epilepsy often requires intracranial monitoring to
delineate the seizure onset zone (SOZ) prior to undergoing surgical

treatment. The concept of epileptogenic zone, described by Rosenow
and Lüders, refers to the cortex required for generation of the patient’s
epileptic seizures and which should be resected to render the patient
seizure free [1]. This region contains the SOZ, which is the actual
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cortical tissue observed to produce the patient’s typical seizures; how
ever, the epileptogenic zone may extend beyond this. Determining the
extent of this boundary is often challenging and requires the clinicians to
examine carefully the neurophysiologic and imaging data. While the
clinical SOZ has a clear role in determining this region, subclinical sei
zures (SCS) are often seen during intracranial EEG, yet their clinical
significance is not certain, especially if there is discordance between
subclinical and clinical SOZ. Several studies examining SCS seen on
subdural grids have been performed. Sperling et al. first reported SCS
were associated with greater seizure freedom in a series of 42 patients
with temporal lobe epilepsy who underwent subdural grid implantation
[2]. Although the study did not specify resection of SCS, the vast ma
jority of SCS were in the amygdala and hippocampus and were pre
sumably included in surgical treatment. A larger study of 111 patients
with subdural grids demonstrated colocalization of subclinical and
clinical seizures to be associated with improved resection outcomes [3].
The majority of these patients had SCS originating in the same location
as clinical seizures, but with less propagation. A smaller series of 27
patients also demonstrated improved outcomes with concordant clinical
and subclinical SOZ [4]. The authors also noted containment of sub
clinical SOZ within surgical resection was associated with good
outcome; however, 2 patients with disparate localization and good
outcome had mesial temporal sclerosis with contralateral SCS and did
not have the subclinical SOZ resected. In addition, incomplete concor
dance or discordance between subclinical SOZ and clinical SOZ was
associated with worse outcomes as well. A recent large pediatric cohort
of 104 patients with subdural grids observed SCS in 63% of patients [5].
The authors did not observe any difference in outcome based on the
presence of SCS but did observe incomplete resection of the subclinical
SOZ was associated with worse surgical outcomes.
Although stereotactic EEG (sEEG) has become a widely adopted
intracranial EEG technique in North America after having a long history
in Europe [6], to our knowledge there are no extensive studies of SCS
recorded on this modality. The broader spacial sampling with sEEG af
fords opportunity to sample disparate structures that would otherwise
not be sampled using subdural grids [7–9]. Given the increasing popu
larity of this modality, it is important to study the role SCS may have in
sEEG monitoring.
We retrospectively reviewed all patients who underwent sEEG in the
Mayo Clinic Enterprise (Minnesota, Florida, and Arizona) and sought to
answer the following questions:

epileptologist; this was confined to electrodes containing the first ictal
change, similar to definitions of SOZ used in previous studies [11–13].
This was applied to both clinical and subclinical seizures. The presence
of SCS was noted, as was whether SCS were seen in sleep, wakefulness,
or both. SCS were defined as electrographic seizures (epileptiform dis
charges >2.5Hz for at least 10 seconds or any pattern with definite
evolution and for at least 10 seconds) with absence of objective or
subjective clinical manifestations. SCS that were induced by stimulation
were excluded, as were SCS due to implantation-related hemorrhage.
The electrodes involved in subclinical SOZ were recorded, as was the
sublobar location. Both clinical and subclinical seizures were classified
as temporal, extratemporal or both. The concordance between subclin
ical and clinical SOZ was classified as complete (same electrodes
involved), partial (the subclinical SOZ was contained within clinical
SOZ) overlapping (some, but not all of the subclinical SOZ electrodes
were contained within clinical SOZ), or no concordance (completely
separate electrodes involved) (Fig. 1). Since the practical differences
between the first and second categories, and between the third and
fourth categories, are negligible (i.e. the first two are all contained
within the same electrodes as clinical SOZ, while the last two contain
electrodes outside of the clinical SOZ), an ad hoc analysis grouping the
concordances as such was also performed. SOZ was defined as earliest
ictal discharge and propagation was not included. For determining sEEG
SOZ as well as whether seizures were subclinical, the sEEG report was
reviewed; however, if this information was not clear in the report the
video sEEG recording was reviewed by the first author. Where possible,
baseline monthly seizure frequency was estimated by chart review of
clinical notes. The number of clinical seizures and SCS recorded on sEEG
were collected by chart review of EEG reports. Patients with imprecise
qualitative descriptions of seizure frequency or seizures recorded (e.g.
“frequent,” “often,” “numerous,” etc.) were not included seizure esti
mations but were included in sEEG analysis if reporting described
electrographic features of each type of seizure.
For each patient, the ultimate surgical treatment was recorded
(resection, laser interstitial thermal therapy [LITT], stimulation, etc).
Destructive procedures including resection, LITT, and disconnection
procedures (excluding corpus callosotomy) were grouped together and
are hereafter referred to as “surgery”. The location of subclinical SOZ in
relation to the surgery site was recorded as complete, partial, or not
treated. For LITT patients, this was determined using the ablation zone
seen on procedural MRI. For focal disconnection patients, the region of
disconnected tissue was used. Concordance was determined by cor
egistering the intracranial electrode locations with pre- and post
operative imaging with allowances being made for expected shift and
architectural distortion. Coregistration was performed using Curry 8.0
software (Neuroscan Compumedics, Charlotte, NC). Pathology was
recorded for patients with resection. Outcomes for all surgical cases
were recorded by retrospective chart review of latest clinic note. Out
comes were classified using the ILAE system and the number of months
of follow up was noted, as well as the month of seizure recurrence. ILAE
class 1 and 2 were classified as “excellent” outcomes.

1 What is the prevalence of SCS on sEEG and what clinical factors are
associated with their presence?
2 To what extent does the subclinical SOZ colocalize with clinical SOZ?
3 Does the presence of SCS influence surgical outcome?
4 Does resection of subclinical SOZ influence surgical outcome?
2. Methods
We reviewed all patients with drug-resistant epilepsy [10] who un
derwent intracranial monitoring with sEEG at Mayo Clinic sites in
Minnesota, Florida, and Arizona from our first implantation (January
2015) through December 2020. Patients were excluded who had sub
dural grid implantation or if sEEG was not performed as part of a pre
surgical evaluation. Patients were also excluded if their habitual seizures
were not captured on sEEG or if SCS were due to implantation-related
hemorrhage.
For each patient, demographic information including age at the time
of sEEG, sex, and MRI abnormalities were recorded. Characteristics of
the sEEG implant including number of electrodes, bilateral vs unilateral
implant, and the number of days recording were noted. The clinical SOZ
electrodes were recorded, as was the lobar and sublobar regions of SOZ.
SOZ was defined as intracranial electrodes that were active initially at
seizure onset and electrodes that later became active with propagation
were excluded based on the clinical judgement of the reviewing

2.1. Statistical analysis
Statistical analysis was performed using BlueSky statistics. Categor
ical variables were compared using Fisher’s exact test with significance
set at p<0.05. Bonferroni correction was used for subgroup testing with
multiple comparisons (excluding 2 comparisons of only a subset of the
cohort). Continuous variables were compared using logistic regression
analysis with confidence intervals calculated using Wald statistics.
Seizure frequency comparisons between groups with and without
recorded SCS were calculated using a Mann-Whitney U test. Kaplan
Meier curves were created to examine the effect of variables on excellent
surgical outcomes and p-values were calculated using log rank method
with values <0.05 considered significant.
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Fig. 1. Categorization of concordance between clinic and subclinical onset zones of 84 patients with subclinical seizures on sEEG.

3. Results

Table 1
Demographics and clinical features of patients undergoing stereotactic EEG.

3.1. Patient and seizure characteristics

Characteristic

There were 174 patients identified who had undergone sEEG moni
toring. Five were excluded (4 did not have typical seizures recorded and
1 patient had a limited implantation performed for spell classification
rather than surgical evaluation), leaving a cohort of 169 patients. The
baseline demographic and clinical characteristics of the remaining 169
patients are presented in Table 1. Eighty-four patients (50%) had SCS
captured on sEEG. Of the 38 patients with bilateral implantation, 34
(89%) had SCS ipsilateral to clinical seizures, 2 (5%) had contralateral,
and 2 had both. SCS were more common in female patients than male
patients (62% vs. 40%, P=0.0054, P <0.00625 significant with Bon
ferroni correction). No difference was seen in the prevalence of SCS
based on the presence of an MRI lesion, temporal vs extratemporal SOZ,
pathology of resected tissue, unifocal vs multifocal clinical SOZ (defined
as differing sublobar locations), or bilateral vs unilateral implant
(Table 2). There did appear to be relatively higher incidence (73%) of
SCS in hippocampal sclerosis, which was our largest pathology type;
however, the number of many of the pathologies in our case series was
too small to draw definite conclusions. A similar number of patients had
SCS in wakefulness alone, sleep alone, or both wakefulness and sleep. Of
the 84 patients with SCS, 34 patients (40%) had complete concordance
with clinical SOZ, 24 (29%) had partial concordance, 15 (19%) had
overlapping concordance, and 9 (12%) were completely discordant
(Fig. 1). No difference in concordance was seen based on the duration of
implantation (mean duration was 5.5, 5.3, 6.8, and 4.6 days,

Age (years) at time of stereo EEG:
Median
Range
Sex:
Male
Female
Subclinical seizures
Clinical seizure onset zone location
Temporal
Extratemporal
Both
Subclinical seizure onset zone location
Temporal
Extratemporal
Both
State during subclinical seizures
Sleep
Wakefulness
Both

N=169(%)
26
3-66
93(55%)
76(45%)
84(50%)
64(38%)
77(46%)
28(17%)
36(42%)
35(41%)
14 17%)
19(23%)
20(24%)
45(54%)

respectively, p=0.38).
Baseline quantitative seizure estimation based on clinical history was
possible in 65 patients without SCS recorded and 74 patients with SCS.
Patients without SCS had a median of 12 seizures per month (IQR 4-40).
Patients with SCS had a median of 8 seizures per month (IQR 3-39).
There was no difference between groups (p=0.20).
Quantitative clinical seizure sEEG data was available for 80 patients
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(28%) underwent neurostimulation therapy and an additional 7 patients
(4%) continued medical management. Twenty-nine patients (17%) were
offered surgery or neurostimulation therapy (11 and 18, respectively)
but had not undergone the procedure at the time of our review. Median
postoperative follow up time for patients who underwent destructive
surgery was 15 months. See Table 3 for full details.
To address the potential influence of SCS on surgical decision mak
ing, the prevalence of SCS was compared in patients undergoing surgery
or neurostimulation as well as patients who were offered either of these
treatments; no differences were seen in prevalence of SCS in those
offered surgery (47/93), those offered neurostimulation (33/66), those
who underwent surgery (44/83), and those who underwent neuro
stimulation (25/47). There was no difference offering surgery based on
grouped concordance of clinical and subclinical seizures (complete/
partial 35/59 vs overlapping/discordant 11/24, p=0.33). Similarly,
there were no differences in offering neurostimulation (complete/partial
20/59 vs overlapping/discordant 13/24, p=0.14).

Table 2
The presence of subclinical seizures in different subgroups. Significant P values
denoted as * (<0.00625 with Bonferroni correction).
Subclinical
Seizure Present
No. (%)

Subclinical
Seizure Absent
No. (%)

All patients (n=169)
Female (n=76)
Male (n=93)

84 (50%)
47(62%)
37 (40%)

85 (50%
29 (38%)
56 (60%)

Lesional MRI (n=103)
Nonlesional MRI
(n=66)
Temporal (n=64)§
Extratemporal
(n=77)§†
Unifocal clinical seizure
onset zone (n=114)
Multifocal clinical
seizure onset zone
(n=55)
Pathology (n=58)†:
Normal/gliosis (n=29)
Lesional (n=29)
- HS (n=11)
- Focal Cortical
Dysplasia Type 1 (n=1)
- Focal Cortical
Dysplasia Type 2a
(n=3)
- Focal Cortical
Dysplasia Type 2b
(n=6)
- Cavernoma (n=2)
- Astrocytoma (n=1)
- Tuber (n=1)
- Periventricular
nodular heterotopia
(n=1)
- cystic
encephalomalacia
(n=1)
- inflammatory
(n=1)
- encephalocele
(n=1)
Unilateral implant
(n=90)
Bilateral implant
(n=79)
Age at time of implant

55 (53%)
29 (44%)

48 (47%)
37 (56%)

34 (53%)
34 (44%)

30 (47%)
43 (56%)

59 (52%)
25 (45%)

55 (48%)
30 (55%)

14 (48%)
18 (62%)
8 (73%)
1 (100%)
1 (33%)
3 (50%)
1 (50%)
0 (0%)
1 (100%)
1 (100%)
0 (0%)
1 (100%)
1 (100%)

15 (52%)
11 (38%)
3 (27%)
0 (0%)
2 (67%)
3 (50%)
1 (50%)
1 (100%)
0 (0%)
0 (0%)
1 (100%)
0 (0%)
0 (0%)

P=0.429, OR
0.576 (0.1761.83)

46 (51%)
38 (48%)

44 (49%)
41 (52%)

0.759, OR 0.887
(0.463-1.70)

25(15.5-34.5)

23(15-35)

5(4-7)

5(4-7)

12(10-13)

12(11-14)

151(133-176)

160(138-180)

0.97, OR 1
(0.978-1.02)
0.534, OR 1
(0.991-1.02)
0.475, OR 0.95
(0.826-1.09)
0.616, OR 1
(0.990-1.01)

Duration of implant
(IQR)
Number of electrodes
(IQR)
Number of contacts
(IQR)

P value, OR (CI
95%)

*P=0.0054, OR
0.4099 (0.2090.794)
P=0.27, OR
1.46 (0.7502.86)
P=0.314, OR
1.43 (0.6992.94)
P=0.512, OR
1.29 (0.6432.59)

3.3. Surgical outcome
Of the 83 patients who underwent a destructive surgery, 44 patients
had subclinical seizures (resection 31, LITT 11, disconnection 2).
Destructive surgery was targeted primarily at the clinical SOZ, however,
anatomical factors such as eloquent cortex or underlying lesion could
alter the surgical margin. Fifty-one surgical patients had at least 1 year
follow up including 27 patients with SCS. There were no differences in
excellent outcomes at 1 year based on the presence of SCS (17/27 vs 18/
24), occurrence of SCS in wakefulness (3/5), sleep (5/8), or both (9/14),
or the concordance of SCS with clinical SOZ (complete 8/13, partial 5/8,
overlapping 3/4, discordant 1/2) (Table 4). An ad hoc analysis grouping
complete and partial together and overlapping and discordant together
was performed, which also did not find any significant difference (15/20
vs 2/7) (Table 4).
There was a trend towards higher rate of excellent 1-year surgical
outcomes in patients with complete destruction of the subclinical SOZ
compared to those with incomplete destruction, but this was not sta
tistically significant (75% vs 29%, P=0.0646) (Table 4). Seventeen
(39%) SCS patients were lost to follow up before 1 year.
A separate analysis comparing Kaplan-Meier curves of all 44 patients
with SCS and surgery demonstrated a significant difference (p=0.013) in
excellent outcomes in patients with complete destruction of the sub
clinical SOZ compared to incomplete destruction (Fig. 2). Of note, 4 out
of 5 patients with incomplete destruction of SCS and poor outcome had
either partial or complete concordance with clinical SOZ (Table 4),
meaning that the clinical SOZ in these patients was also incompletely
treated. Also, none of the patients who underwent surgery had SCS
Table 3
Ultimate treatments patients received after stereotactic EEG.

excluding 28 patients with SOZ including temporal and extratemporal.
†
subgroup of 58 patients who underwent resection and had pathology
available.
§

without SCS and 73 patients with SCS. Patients without SCS had a me
dian of 4 clinical seizures recorded (IQR 3-8) and patients with SCS had a
median of 4 clinical seizures recorded (IQR 3-10). There was no differ
ence between groups (p=0.51).
Quantitative SCS sEEG data was available for 54 patients, with a
median of 3 seizures recorded (IQR 1-6).
3.2. Surgical treatments
Of all patients, 83 (49%) underwent a destructive surgical procedure
with 3 additional patients (2%) undergoing a palliative surgery (2
corpus callosotomy and 1 palliative resection). Forty-seven patients

Treatment

N=169(%)

Surgery
Resection
LITT
Focal disconnection
Palliative surgery
corpus callosotomy
palliative resection
Stimulation
Deep Brain Stimulation (DBS)
Responsive Neurostimulation (RNS)
Vagal Nerve Stimulation (VNS)
Chronic Subthreshold Cortical stimulation (CSCS)
CSCS+DBS
Medtronic Summit RC+S device(19)
Offered surgery but not done
Offered stimulation but not done
Medical management

83 (49%)
60
21
2
3 (2%)
2
1
47 (28%)
12
9
14
9
1
2
11 (7%)
18 (11%)
7 (4%)
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ILAE1-2 at 1
year

P value, OR (CI 95%)

originating from the opposite hemisphere. Kaplan-Meier curves
comparing outcomes based on presence versus absence of SCS, presence
of SCS during wakefulness or sleep, and the degree of concordance of
SCS with clinical SOZ did not show a significant difference.

17 (63%)
18 (75%)

P=0.38, OR 0.573 (0.138-2.20)

4. Discussion

3 (60%)
5 (63%)
9 (64%)

P=0.93

8(62%)
5(63%)
3(75%)
1(50%)

P=0.93

13 (62%)
4 (67%)

P=1.00, OR 1.32 (0.145-16.46)

15 (75%)
2(29%)

P=0.0646, OR 0.146 (0.01061.23)

Table 4
1-year outcomes for patients who underwent destructive surgery (including
resection, laser interstitial thermotherapy, and focal disconnection).

SCS (n=27)
No SCS (n=24)
State during subclinical
seizures
Sleep (n=5)
Wakefulness (n=8)
Both (n=14)
Concordance w/ clinical SOZ
Complete (n=13)
Partial (n=8)
Overlapping (n=4)
Discordant (n=2)
Grouped concordance
Complete/partial (n=21)
Overlapping/discordant
(n=6)
SCS destruction
Complete (n=20)
Incomplete (n=7)

To our knowledge, this is the largest cohort describing SCS seen in
adults and children using sEEG. SCS were relatively common finding
seen in 50% of our cohort. Surgical treatment of subclinical SOZ was
found to have a significant association with excellent outcome from a
destructive surgical procedure. Although the number of patients with
incomplete destruction of subclinical SOZ was smaller than those with
complete destruction (10 vs 34) the groups were powered sufficiently to
detect a difference. These findings suggest that SCS represent an
important component of the ictal network that should not be ignored in
surgical planning.
There was no association with the presence of SCS and 1-year sur
gical outcomes. There was no difference in excellent outcomes based on
the degree of overlap between subclinical and clinical seizure onset
zones. This latter finding differs from a prior study of subdural re
cordings, which saw that co-localization of subclinical seizures with

Fig. 2. Kaplan-Meier curve demonstrating the probability of excellent surgical outcome (ILAE 1 or 2) based on complete or incomplete treatment of subclinical SOZ.
Incomplete treatment included both partially treated and not treated subclinical SOZ.
100
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clinical seizures was associated with improved outcomes [2]. Of note,
the prior study did not examine whether SCS were contained within the
resection margins, which is an important factor in determining the
impact of SCS on outcomes. Also, similar to our study, there were
smaller numbers of patients with discordant co-localization compared to
concordant localization. A recent pediatric study, which did account for
completeness of the resection, reported a similar result as our study [4].
Most of our clinical variables including presence of MRI lesion,
multifocal seizures, temporal or extratemporal location, duration of
implant, or number of electrode contacts were not associated with the
presence of SCS, similar to the recent pediatric study [5]. There did
appear to be a higher rate of SCS in hippocampal sclerosis; however, the
small sample size of other “lesional” pathologies was too small to draw
conclusions. Certainly, this finding fits with the known epileptogenicity
of this pathology.
The increased rate of SCS in female patients compared to male pa
tients was an unexpected finding; it is possible that other variables not
examined could explain this difference, such as seizure medications or
degree of weaning off meds; however, given the known hormonal in
fluences on neuronal excitability and seizures [14], it is conceivable that
there could be a hormonal role in the genesis of SCS.
Despite sEEG offering a wider spacial sampling of seizure networks,
there did not appear to be a higher incidence of SCS in our cohort (50%)
compared to prior subdural grid cohorts (64%(3) and 63%(5)), although
differences in patient characteristics could certainly affect this. It is
possible that sEEG allows for better delineation of partial and over
lapping concordance with clinical SOZ due to better sampling of deep
structures; however, this is speculative. Either modality presents a
certain degree of sampling bias in detecting and delineating subclinical
and clinical seizures.
SCS represent an important component of ictal networks. The lack of
clinical features may simply reflect the nature of the underlying cortex it
arises from (i.e. lack of eloquence or involvement in consciousness),
however, as clinical semiology is a much more complex network process
produced by interconnected structures [15], SCS may reflect a node that
has not yet reached threshold to activate such a network. Subclinical
SOZ appear represent a critical irritative focus in the ictal network that
does not involve enough tissue to produce symptoms– the fact that in the
majority of patients (69%) SCS colocalized with or were contained
within the clinical SOZ supports this hypothesis. The less favorable
surgical outcomes seen in our patients with incomplete treatment of the
SOZ highlight their importance in ictal networks; SCS with disparate
localization may indicate more diffuse involvement or could also
represent a separate node in the ictal network that could allow for
recurrence of seizures if untreated. [4, 16, 17]
The question may arise of whether surgical resection may be pursued
in the presence of SCS alone; given our data and others demonstrating
moderate to high degree of concordance with clinical seizure onset zone
(55.3-90%)(4, 16, 17). While ideally the patient’s habitual seizures
should be recorded, concordance of SCS with other factors such as
semiology, lesion, or functional data may allow the surgical team to
pursue resection in the absence of observed clinical seizures. Stimulation
studies could add further certainty in such a situation.
Our study is limited by its retrospective nature; although we did not
see a difference in surgical decision based on the presence of SCS in our
cohort, it is hard to rule out this bias in surgical decision making,
especially when there is discordance with the clinical SOZ. Retrospec
tive data collection of seizure frequency both at baseline clinically and
recorded on SEEG is limited in many patients by qualitative rather than
quantitative descriptions in several patients, especially in patients with
SCS with 30 patients having “numerous” or “innumerable” seizures,
making interpretation of those variables difficult and in the case of sEEG
recorded seizures an underestimation. Our study also did not examine
variables such as the relative burden of SCS compared to clinical seizures
or the distance between clinical and subclinical SOZ. A larger cohort of
patients who had undergone surgical treatment could have addressed

the limitation due to small subgroups of patients. While we excluded
patients with SCS due to acute hemorrhage from electrode placement,
we did not specifically look at the presence of edema related to electrode
implantation, which can occur with sEEG and could be a potential cause
of SCS [18]. Also, it is important to note that none of our patients who
had SCS arising in the opposite hemisphere underwent surgical treat
ment, which limits the application of our findings in this situation. It
should also be noted that our study involved spontaneous SCS, which did
not include SCS provoked during electrocortical stimulation mapping
for eloquent functions of brain regions.
5. Conclusion
SCS are a common finding on stereo EEG recordings. Our study
shows that SCS often arise within the same regions as clinical seizures.
When there is discordance between clinical and subclinical SOZ, it is
important to consider including the SCS in the surgical plan when
feasible as failing to treat the subclinical SOZ is associated with worse
surgical outcomes. While SCS have not traditionally been considered as
part of the clinical SOZ, our data suggests they should be considered at
least part of the epileptogenic zone.
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